VPREB1: A Protein Target for Psychiatric Disorders (G7441)

Target Name: VPREB1

NCBI ID: G7441

VPREB1

VPREB1: A Protein Target for Psychiatric Disorders

VPREB1 (Igiodine) is a protein that is expressed in the Interneuron, a type of nerve cell that is responsible for transmitting signals in the brain. It is a key regulator of neuron development and function, and is involved in the formation of neural connections.

Research has identified VPREB1 as a potential drug target for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. The reason for this is that these conditions are characterized by the progressive loss of neurons and the formation of aggregates of neurotransmitters, which can disrupt the normal functioning of the brain.

One of the key features of VPREB1 is its role in the formation of synapses, which are the connections between neurons. Synapses are critical for the transmission of signals in the brain, and changes in their structure or function can have a significant impact on brain function.

In Alzheimer's disease, the loss of synapses is thought to contribute to the progression of the disease. The formation of aggregates of the neurotransmitter tau, which are thought to play a role in the development of these aggregates, may also be involved in the destruction of synapses.

In Parkinson's disease, the loss of dopamine-producing neurons in the brain is thought to contribute to the progressive symptoms of the disease. The formation of aggregates of dopamine may also be involved in the destruction of these neurons.

In depression, changes in the levels of neurotransmitters such as serotonin and norepinephrine may be involved in the symptoms of this condition. The formation of aggregates of these neurotransmitters may also contribute to the disruption of synapses.

In addition to its role in the formation of synapses, VPREB1 is also involved in the regulation of neuron survival. Studies have shown that VPREB1 plays a role in the survival and proliferation of neuron cells, and that its levels are reduced in the brains of individuals with depression and other psychiatric disorders.

The potential drug target for VPREB1 is due to its ability to modulate the levels of neurotransmitters, as well as its role in the regulation of neuron survival. This makes it an attractive target for the development of new treatments for a variety of psychiatric and neurological disorders.

In conclusion, VPREB1 is a protein that is expressed in the Interneuron and is involved in the formation of synapses, as well as the regulation of neuron survival. Its potential as a drug target makes it an attractive target for the development of new treatments for a variety of psychiatric and neurological disorders. Further research is needed to fully understand the role of VPREB1 in the development and progression of these conditions.

Protein Name: V-set Pre-B Cell Surrogate Light Chain 1

Functions: Associates with the Ig-mu chain to form a molecular complex that is expressed on the surface of pre-B-cells. This complex presumably regulates Ig gene rearrangements in the early steps of B-cell differentiation

The "VPREB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VPREB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets